Cyclic flow variations after angioplasty: A rare phenomenon predictive of immediate complications

American Heart Journal

Volumn 131, Issue 5, 1996, Pages 843-848

  Sunamura, Madoka ^a   Di Mario, Carlo ^a   Piek, Jan J ^a   Schroeder, Erwin ^a   Vrints, Chris ^a   Probst, Peter ^a   Heyndrickx, Guy R ^a   Fleck, Eckart ^a   Serruys, Patrick W ^a,b  

^a Erasmus University ^*

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DOPPLER FLOWMETRY; FEMALE; GUIDE WIRE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0029915229     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90162-3     Document Type: Article

References (30)

1. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54:365-70.
2. Ikeda H, Koga Y, Kuwano K, Nakayama H, Ueno T, Yoshida N, Adachi K, Park IS, Toshima H. Cyclic flow variations in a conscious dog model of coronary artery stenoses and endothelial injury correlate with acute ischemic heart disease syndromes in humans. J Am Coll Cardiol 1993;21:1008-17.
3. Eichhorn EJ, Grayburn PA, Willard JE, Anderson HV, Bedotto JB, Carry M, Kahn JK, Willerson JT. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol 1991;17:43-52.
4. Anderson HV, Kirkkeeide RL, Krishnaswami A, Weigelt LA, Revana M, Weisman HF, Willerson JT. Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody. J Am Coll Cardiol 1994;23:1031-7.
5. Flynn MS, Kern MJ, Aguirre FV, Bach RG, Caracciolo EA, Donohue TJ. Alterations in coronary blood flow velocity during intracoronary thrombolysis and rescue coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn 1994;31:219-24.
6. Anderson HV, Kirkeeide RL, Stuart Y, Smalling RW, Heibig J, Wilierson JT. Coronary artery flow monitoring following coronary interventions. J Am Coll Cardiol 1993;71:62D-9D.
7. Folts JD, Gallagher KP, Rowe GG. Cyclical flow reductions in arterial blood flow in stenosed canine coronary arteries: vasospasm or platelet aggregation? Circulation 1982;65:248-55.
8. 2 receptor blockade provide protection against epinephrine induced cyclic flow variations in severely narrowed canine coronary arteries. J Am Coll Cardiol 1989;13:755-63.
9. Yao S-K, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992;86:1302-9.
10. Anderson HV, Yao S-K, Murphree SS, Buja LM, McNatt JM, Willerson JT. Cyclic coronary artery flow in dogs after coronary angioplasty. Coronary Artery Dis 1990;1:717-23.
11. Doucette JW, Douglas CP, Payne HP, Flynn AE, Goto M, Nassi M, Segal J. velocity. Circulation 1992;85:1899-911.
12. Keane D, Haase J, Slager CJ, Montauban van Swijndregt E, Lehmann KG, Ozaki Y, di Mario C, Kirkeeide R, Serruys PW. Comparative validation of quantitative coronary angiography systems: results and implications from a multicenter study using a standardized approach. Circulation 1995;91:2174-83.
13. Detre KM, Holmes DR, Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, Dorros GP, Bentivoglio LB, Kent KM, Myler RK, coinvestigators of the NHLBIPTCA Registry. Incidence and consequences of periprocedural occlusion: the 1985-1986 NHLBI PTCA Registry. Circulation 1990;82:739-50.
14. Ambrose JA, Winters SL, Stern A. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985;5:609-16.
15. de Feyter PJ, van den Brand M, Laarman GJ, van Domburg R, Serruys PW, Suryapranata H. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Circulation 1991; 83:927-36.
16. Kern MJ, Aguirre FV, Donohue TJ, Bach RG, Caracciolo EA, Flynn MS, Wolford T, Moore JA. Continuous coronary flow velocity monitoring during coronary interventions: velocity trend patterns associated with adverse events. AM HEART J 1994;128:426-34.
17. Waller BF, Orr CM, Pinkerton CA, van Tassel J, Peters T, Slack JD. Coronary balloon angioplasty dissections: "the good, the bad and the ugly." J Am Coll Cardiol 1992;20:701-6.
18. Serruys PW, Juilliere Y, Zijlstra F, Beatt KJ, de Feyter PJ, Suryapranata H, van den Brand M, Roelandt J. Coronary blood flow velocity during percutaneous transluminal coronary angioplasty as a guide for assessment of functional result. Am J Cardiol 1988;61:253-9.
19. Hermans WR, Rensing BJ, Foley DP, et al. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR study group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis). J Am Coll Cardiol 1992;20:767-80.
20. Bredlau C, Roubin GS, Leimgruiber PP, Douglas JS, King SB, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985;72:1044-52.
21. de Feyter PJ. Coronary angioplasty for unstable angina. AM HEART J 1989;118:860-8.
22. Marmur JD, Merlini PA, Sharma SK, et al. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol 1995;24:1484-91.
23. Tcheng JE, Ellis SG, George BS, Kereiakes DJ, Kleiman NS, Talley JD, Wang AL, Weisman HF, Califf RB, Topol EJ. Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 1994;90:1757-64.
24. Anderson HV, Levanna M, Resales O. Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty. Am J Cardiol 1992;69:1373-6.
25. Serruys PW, Fox KAA, Herrman JPR, Bach D, Close P, Deckers JW, HELVETICA investigators. Recombinant-hirudin (CGP 39 393) reduces the incidence of major adverse cardiac events, reported within the first 96 hours post-angioplasty in unstable patients (Braunwald classification) pre-treated by heparin. J Am Coll Cardiol 1995;25:80A.
26. Ambrose JA, Almeida OD, Sharma SK, et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the TAUSA trial. Circulation 1994;90:69-77.
27. den Heijer P, van Dijk RB, Hillege HL, Pentinga ML, Serruys PW, Lie KI. Serial angioscopic and angiographie observations during the first hour after successful coronary angioplasty: a preamble to a multicenter trial addressing angioscopic markers for restenosis. AM HEART J1994; 128:656-63.
28. Hirsch PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 1981;304:685-91.
29. Van den Berg EK, Schmitz JM, Bemedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation 1989;79:116-24.
30. Kern MJ, Aguirre FV, Donohue TJ, et al. Coronary flow velocity monitoring after angioplasty associated with abrupt reocclusion. AM HEART J 1994;127:436-8.